Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05591014 · ClinicalTrials.gov registry record · NA

The Effectiveness of a Novel Software Program to Help in ROTEM Interpretation

A NA study, sponsored by University of Utah.

Completed
Registry status
NA
Development phase
26
Enrollment target

NCT05591014 is a NA study that has completed, run by University of Utah. The registered enrollment target is 26 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05591014, a NA study, has completed, sponsored by University of Utah.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target

Study Summary

The purpose of this study is to assess a novel rotational thromboelastometry (ROTEM®) interpretation software to determine whether its use improves the accuracy of clinician interpretation.

Interventions

  • DEVICE Novel ROTEM interpretation software

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2023-04-13
Est. Completion 2024-12-31
Phase NA

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT05591014

The ClinicalTrials.gov registry entry for NCT05591014 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Novel ROTEM interpretation software is the first listed.

NCT05591014 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05591014 about?

NCT05591014 is a clinical study titled "The Effectiveness of a Novel Software Program to Help in ROTEM Interpretation". The purpose of this study is to assess a novel rotational thromboelastometry (ROTEM®) interpretation software to determine whether its use improves the accuracy of clinician interpretation.

What is the current status of trial NCT05591014?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2023-04-13. Estimated completion is 2024-12-31.

What interventions are being tested in trial NCT05591014?

The interventions under investigation include: Novel ROTEM interpretation software (DEVICE).

Who is sponsoring clinical trial NCT05591014?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.